Bausch Health Companies (BHC) Change in Inventory (2009 - 2026)
Bausch Health Companies (BHC) posted Change in Inventory of $22.0 million for Q2 2026, up 57.14% sequentially from $14.0 million in Q1 2026, and up 414.29% YoY from $4.3 million in Q2 2025.
Bausch Health Companies (BHC) Change in Inventory (2009 - 2026) Analysis & Trends
Bausch Health Companies has reported Change in Inventory for 18 years, with the latest figure at $22.0 million in Q2 2026.
- Quarterly Change in Inventory rose 414.29% year-over-year to $22.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $25.0 million (down 78.07% YoY) and the FY2025 annual result came in at $12.0 million, down 95.51% from the prior year.
- Change in Inventory rose to $22.0 million in Q2 2026 per BHC's latest filing, from $14.0 million in the prior quarter.
- Over five years, Change in Inventory peaked at $144.0 million in Q1 2024 and troughed at -$16.0 million in Q3 2025.
- A 5-year average of $46.4 million and a median of $37.0 million in 2023 frame the typical range for Change in Inventory.
- The sharpest annual moves came in 2023 and 2025: Change in Inventory soared 2400.0% in 2023, then plunged 138.1% in 2025.
- Over 5 years, Change in Inventory stood at $4.0 million in 2022, then jumped by 2400.0% to $100.0 million in 2023, then plunged by 51.0% to $49.0 million in 2024, then sank by 89.8% to $5.0 million in 2025, then soared by 340.0% to $22.0 million in 2026.
- According to Business Quant data, Change in Inventory over the past three periods registered $22.0 million, $14.0 million, and $5.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -59.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 23.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -209.58 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 17.70 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 99.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 6.50 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Bausch Health Companies | 2.56 Bn | 725.13 Mn | 2.10 Bn | 22.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 22.00 Mn |
| Jun 30, 2026 | 22.00 Mn |
| Mar 31, 2026 | 14.00 Mn |
| Mar 31, 2026 | 14.00 Mn |
| Dec 31, 2025 | 5.00 Mn |
| Dec 31, 2025 | 5.00 Mn |
| Sep 30, 2025 | -16.00 Mn |
| Sep 30, 2025 | -16.00 Mn |
| Jun 30, 2025 | -7.00 Mn |
| Jun 30, 2025 | -7.00 Mn |
| Mar 31, 2025 | 30.00 Mn |
| Mar 31, 2025 | 30.00 Mn |
| Dec 31, 2024 | 49.00 Mn |
| Dec 31, 2024 | 49.00 Mn |
| Sep 30, 2024 | 42.00 Mn |
| Sep 30, 2024 | 42.00 Mn |
| Jun 30, 2024 | 32.00 Mn |
| Jun 30, 2024 | 32.00 Mn |
| Mar 31, 2024 | 144.00 Mn |
| Mar 31, 2024 | 144.00 Mn |